Toward a More Precise Solution to Asthma Therapy
- PMID: 34153196
- PMCID: PMC8485991
- DOI: 10.1165/rcmb.2021-0227ED
Toward a More Precise Solution to Asthma Therapy
Figures
Comment on
-
TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.Am J Respir Cell Mol Biol. 2021 Sep;65(3):309-318. doi: 10.1165/rcmb.2021-0042OC. Am J Respir Cell Mol Biol. 2021. PMID: 34003734
References
-
- Global Initiative for Asthma Global strategy for asthma management and prevention. Fontana, WI: Global Initiative for Asthma; http://www.ginasthma.org/
-
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373. - PubMed
-
- Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391:783–800. - PubMed
-
- Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, Green FH, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 2002;295:336–338. - PubMed
